Dopamine Targeting Drugs for the Treatment of Schizophrenia: Past, 
Present and Future

Schizophrenia is a chronic and debilitating neuropsychiatric disorder affecting approximately 1% of the world’s population. This disease is associated with considerable morbidity placing a major financial burden on society. Antipsychotics have been the mainstay of the pharmacological treatment of sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Peng, Snyder, Gretchen L., Vanover, Kimberly E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112764/
https://www.ncbi.nlm.nih.gov/pubmed/27291902
http://dx.doi.org/10.2174/1568026616666160608084834

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5112764/
https://www.ncbi.nlm.nih.gov/pubmed/27291902
http://dx.doi.org/10.2174/1568026616666160608084834

Ejemplares similares